Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 459

1.

Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria.

Leuzzi V, Bianchi MC, Tosetti M, Carducci CL, Carducci CA, Antonozzi I.

J Inherit Metab Dis. 2000 Sep;23(6):563-70.

PMID:
11032331
[PubMed - indexed for MEDLINE]
2.

The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) study.

Leuzzi V, Tosetti M, Montanaro D, Carducci C, Artiola C, Carducci C, Antonozzi I, Burroni M, Carnevale F, Chiarotti F, Popolizio T, Giannatempo GM, D'Alesio V, Scarabino T.

J Inherit Metab Dis. 2007 Apr;30(2):209-16. Epub 2007 Jan 23.

PMID:
17245558
[PubMed - indexed for MEDLINE]
3.

[Magnetic resonance imaging of the brain in phenylketonuria].

Izumi M, Yamazaki H, Nakabayashi H, Owada M.

No To Hattatsu. 2006 Jan;38(1):27-31. Japanese.

PMID:
16447793
[PubMed - indexed for MEDLINE]
4.

Phenylketonuria: white-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion.

Scarabino T, Popolizio T, Tosetti M, Montanaro D, Giannatempo GM, Terlizzi R, Pollice S, Maiorana A, Maggialetti N, Carriero A, Leuzzi V, Salvolini U.

Radiol Med. 2009 Apr;114(3):461-74. doi: 10.1007/s11547-009-0365-y. Epub 2009 Mar 10. English, Italian.

PMID:
19277839
[PubMed - indexed for MEDLINE]
5.

1H MR chemical shift imaging detection of phenylalanine in patients suffering from phenylketonuria (PKU).

Sijens PE, Oudkerk M, Reijngoud DJ, Leenders KL, de Valk HW, van Spronsen FJ.

Eur Radiol. 2004 Oct;14(10):1895-900. Epub 2004 Aug 3.

PMID:
15378255
[PubMed - indexed for MEDLINE]
6.

Identification and quantitation of phenylalanine in the brain of patients with phenylketonuria by means of localized in vivo 1H magnetic-resonance spectroscopy.

Kreis R, Pietz J, Penzien J, Herschkowitz N, Boesch C.

J Magn Reson B. 1995 Jun;107(3):242-51.

PMID:
7788097
[PubMed - indexed for MEDLINE]
7.

Blood-brain phenylalanine relationships in persons with phenylketonuria.

Koch R, Moats R, Guttler F, Guldberg P, Nelson M Jr.

Pediatrics. 2000 Nov;106(5):1093-6.

PMID:
11061780
[PubMed - indexed for MEDLINE]
8.

The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.

Schindeler S, Ghosh-Jerath S, Thompson S, Rocca A, Joy P, Kemp A, Rae C, Green K, Wilcken B, Christodoulou J.

Mol Genet Metab. 2007 May;91(1):48-54. Epub 2007 Mar 23.

PMID:
17368065
[PubMed - indexed for MEDLINE]
9.

Biochemical, clinical and neuroradiological (MRI) correlations in late-detected PKU patients.

Leuzzi V, Trasimeni G, Gualdi GF, Antonozzi I.

J Inherit Metab Dis. 1995;18(5):624-34.

PMID:
8598645
[PubMed - indexed for MEDLINE]
10.

Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria.

Rupp A, Kreis R, Zschocke J, Slotboom J, Boesch C, Rating D, Pietz J.

J Cereb Blood Flow Metab. 2001 Mar;21(3):276-84.

PMID:
11295882
[PubMed - indexed for MEDLINE]
Free Article
11.

Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria.

Möller HE, Weglage J, Bick U, Wiedermann D, Feldmann R, Ullrich K.

Pediatrics. 2003 Dec;112(6 Pt 2):1580-3.

PMID:
14654669
[PubMed - indexed for MEDLINE]
12.

Localized brain proton NMR spectroscopy in young adult phenylketonuria patients.

Johannik K, Van Hecke P, François B, Marchal G, Smet MH, Jaeken J, Breysem L, Wilms G, Baert AL.

Magn Reson Med. 1994 Jan;31(1):53-7.

PMID:
8121269
[PubMed - indexed for MEDLINE]
13.

Reproducibility of cerebral phenylalanine levels in patients with phenylketonuria determined by 1H-MR spectroscopy.

Kreis R, Zwygart K, Boesch C, Nuoffer JM.

Magn Reson Med. 2009 Jul;62(1):11-6. doi: 10.1002/mrm.21983.

PMID:
19353664
[PubMed - indexed for MEDLINE]
14.

Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency.

Pietz J, Meyding-Lamadé UK, Schmidt H.

Eur J Pediatr. 1996 Jul;155 Suppl 1:S69-73.

PMID:
8828614
[PubMed - indexed for MEDLINE]
15.

Cerebral energy metabolism in phenylketonuria: findings by quantitative In vivo 31P MR spectroscopy.

Pietz J, Rupp A, Ebinger F, Rating D, Mayatepek E, Boesch C, Kreis R.

Pediatr Res. 2003 Apr;53(4):654-62. Epub 2003 Feb 20.

PMID:
12612190
[PubMed - indexed for MEDLINE]
16.

Magnetic resonance imaging of the brain in phenylketonuria.

Cleary MA, Walter JH, Wraith JE, Jenkins JP, Alani SM, Tyler K, Whittle D.

Lancet. 1994 Jul 9;344(8915):87-90.

PMID:
7912392
[PubMed - indexed for MEDLINE]
17.

Clinical analysis of West syndrome associated with phenylketonuria.

Zhongshu Z, Weiming Y, Yukio F, Cheng-LNing Z, Zhixing W.

Brain Dev. 2001 Nov;23(7):552-7.

PMID:
11701254
[PubMed - indexed for MEDLINE]
18.

Phenylalanine can be detected in brain tissue of healthy subjects by 1H magnetic resonance spectroscopy.

Pietz J, Lutz T, Zwygart K, Hoffmann GF, Ebinger F, Boesch C, Kreis R.

J Inherit Metab Dis. 2003;26(7):683-92.

PMID:
14707517
[PubMed - indexed for MEDLINE]
19.

The dynamics of brain concentrations of phenylalanine and its clinical significance in patients with phenylketonuria determined by in vivo 1H magnetic resonance spectroscopy.

Pietz J, Kreis R, Boesch C, Penzien J, Rating D, Herschkowitz N.

Pediatr Res. 1995 Nov;38(5):657-63.

PMID:
8552430
[PubMed - indexed for MEDLINE]
20.

In vivo measurement of phenylalanine in human brain by proton nuclear magnetic resonance spectroscopy.

Novotny EJ Jr, Avison MJ, Herschkowitz N, Petroff OA, Prichard JW, Seashore MR, Rothman DL.

Pediatr Res. 1995 Feb;37(2):244-9.

PMID:
7731764
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk